BD to Begin Remediation for BD Alaris™ System Software


FRANKLIN LAKES, N.J., July 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall through a new version of software. (US Food Recalls) More More

Similar stories

BD posts revenue gains, FY24 forecast as it closes in on 2025 strategy - Fierce Biotech

BD posts revenue gains, FY24 forecast as it closes in on 2025 strategy  Fierce Biotech

Posted on 9 November 2023 | 3:00 am | Google News

With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps - Fierce Biotech

With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps  Fierce Biotech

Posted on 24 July 2023 | 2:00 am | Google News

Spring-loaded: BD poised to jump on pent up demand for updated Alaris following long-awaited FDA clearance - BioWorld Online

Spring-loaded: BD poised to jump on pent up demand for updated Alaris following long-awaited FDA clearance  BioWorld Online

Posted on 24 July 2023 | 2:00 am | Google News

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System - PR Newswire

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System  PR Newswire

Posted on 21 July 2023 | 2:00 am | Google News

FDA clears updated BD Alaris infusion system after long-term commercial hold - Drug Delivery Business News

FDA clears updated BD Alaris infusion system after long-term commercial hold  Drug Delivery Business News

Posted on 21 July 2023 | 2:00 am | Google News

BD begins remediation in Alaris infusion system software recall - Drug Delivery Business News

BD begins remediation in Alaris infusion system software recall  Drug Delivery Business News

Posted on 29 July 2021 | 2:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info